Table 1.
Baseline characteristics of HIV-1-infected children receiving antiretroviral therapy
| Characteristics | Total |
|---|---|
| n (%) or median (IQR) | |
| Age (years) | |
| 0–5 | 345(36.7) |
| 6–15 | 596(63.3) |
| Median(IQR) | 3.6(1.7–6.8) |
| Sex | |
| Male | 453(48.1) |
| Female | 488(51.9) |
| BMI z-score | |
| >−3.0 | 781(85.3) |
| ≤−3.0 | 135(14.7) |
| Median(IQR) | -0.6(-2.0–-0.4) |
| WHO clinical stage | |
| Stage 1 and 2 | 487(55.7) |
| Stage 3 and 4 | 387(44.3) |
| Severe immunosuppression** | |
| Present | 369(42.9) |
| Absent | 492(57.1) |
| CD4 cell count(cells/μL) | 508(252–842) |
| CD4 (%) | 17(10–26) |
| Viral load(copies/mL) | 444,480(6638–202,186) |
| Log viral load(copies/mL) | 10.7(8.8–12.2) |
| Haemoglobin level(g/dL) | 10(9–11) |
| Platelet count(×103/μL) | 327(243–426) |
| Total WBC count(×103/μL) | 7.4(5.3–9.9) |
| Total lympohcyte count(×103/μL) | 3.6(2.4–5.3) |
| Total neutrophil count(×103/μL) | 2.4(1.7–3.7) |
| Anaemia | |
| Present | 58(6.4) |
| Absent | 847(93.6) |
| Thrombocytopenia | |
| Present | 63(7.0) |
| Absent | 838(93.0) |
| Leukopenia | |
| Present | 78(8.6) |
| Absent | 827(91.4) |
| Lymphopenia | |
| Present | 13(1.4) |
| Absent | 891(98.6) |
| Neutropenia | |
| Present | 45(5.0) |
| Absent | 853(95.0) |
Data are presented as number(%) or median(interquartile range(IQR)).
BMI: body mass index; WBC: white blood cells.
**
HIV severe immunodeficiency based on World Health Organization (WHO) classification.